SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Eaton Vance Tax-Advantaged Dividend Income Fund (EVT) News

Follow Eaton Vance Tax-Advantaged Dividend Income Fund (EVT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol EVT Asset equity Sector Markets 90 days 8 Last 27.45 Updated Oct 14, 2026, 06:07 AM UTC Open live news feed Open EVT chart & news
M Evotec Says Preliminary Nine-Month 2026 Results Top Market Expectations Evotec said preliminary results for the first nine months of 2026 were above market expectations. EARNINGS | Oct 14, 2026, 06:07 AM UTC L Evotec SE (EVT) CSO To Step Down Sept. 30, 2026 Evotec SE announced that Chief Scientific Officer Dr. Cord Dohrmann will step down effective Sept. 30, 2026; the search for his replacement is ongoing.Material DetailsContext by AI AnalystThis is a management transition NEWS | Sep 29, 2026, 06:05 AM UTC L Evotec Announces Chief Scientific Officer Transition HAMBURG, Germany, Sept. 29, 2026 // -- Evotec SE (NASDAQ:EVO) (Frankfurt Prime Standard: EVT) today announced that Chief Scientific Officer (CSO) Dr. Cord Dohrmann will step down effective September 30, 2026. The decisio NEWS | Sep 29, 2026, 06:05 AM UTC L Evotec SE releases voting rights notice under WpHG Article 40 Evotec SE filed a voting rights announcement release under Article 40, Section 1 of the WpHG, with the objective of Europe-wide distribution. The item was transmitted via EQS News. REGULATION | Sep 10, 2026, 10:21 AM UTC L Evotec starts Phase 1 trial for Jst-018 orthopoxvirus antibodies Evotec initiated a Phase 1 trial for Jst-018 antibodies targeting orthopoxviruses. EQUITY | Sep 09, 2026, 05:34 AM UTC L Evotec and Plectonic launch research collaboration for solid tumors immunotherapy Evotec SE and Plectonic Biotech announced a research collaboration to explore a novel immunotherapy approach for solid tumors. EQUITY | Sep 02, 2026, 06:05 AM UTC L Eaton Vance Closed-End Funds Release Estimated Sources of Distributions Eaton Vance Closed-End Funds Release Estimated Sources of Distributions EQUITY | Aug 31, 2026, 08:15 PM UTC L Evotec SE WpHG Article 40 release for Europe-wide distribution Evotec SE said it will release information under Article 40, Section 1 of the WpHG for Europe-wide distribution. EQUITY | Aug 31, 2026, 03:43 PM UTC